Baylis, Françoise
Permanent URI for this collectionhttps://hdl.handle.net/10222/15763
Browse
Recent Submissions
Item Open Access The HFEA public consultation process on hybrids and chimeras: informed, effective, and meaningful?(2009-03) Baylis, F.In September 2007, the Human Fertilisation and Embryology Authority (HFEA) in the United Kingdom concluded that "there is no fundamental reason to prevent cytoplasmic hybrid research ... this area of research can, with caution and careful scrutiny, be permitted." Later, in January 2008, HFEA issued two research licenses to create humanesque cytoplasmic hybrid embryos from which stem cells could be derived. This article critically examines the public consultation process that preceded these decisions, concluding that the process was flawed and demonstrating how the HFEA documents summarizing the findings of the public consultation process misrepresent the public's contributions to this policymaking initiative.Item Open Access Promises and perils of cognitive performance tools: A dialogue(2007) Viirre, Erik; Baylis, Françoise; Downie, JocelynCognitive performance tools are evolving and their application is expanding rapidly. Although these tools promise significant advantages, they also raise a number of significant ethical and social concerns. This paper first provides an overview of various cognitive performance tools. Subsequently, there is a dialogue between Viirre on the one hand and Baylis and Downie on the other. Together, they explore the promises and perils of cognitive performance tools available now, or in the near future (perhaps within the next ten to twenty years). The authors conclude there are potential benefits with the development and use of cognitive performance tools. Care must be taken, however, with respect to the ways in which such tools may not serve the interests of individuals and communities.Item Open Access Confusion worse confounded. British Medical Journal [Rapid Response: Withdrawal of clinical trials policy by Canadian research institute is a “lost opportunity for increased transparency” by Ann Silversides. British Medical Journal 2011;342:d2570].(BMJ Publishing, 2011-05-04) Baylis, Françoise; Downie, JocelynRapid response to "Withdrawal of clinical trials policy by Canadian research institute is a 'lost opportunity for increased transparency'" by Ann Silversides.Item Open Access Access to health care for women. [Letter to the Editor](New England Journal of Medicine, 1997) Baylis, Françoise; Nelson, Hilde LindemannLetter to the editorItem Open Access Chimera Research and Stem Cell Therapies for Human Neurodegenerative Disorders(Cambridge University Press, 2007) Baylis, Françoise; Fenton, AndrewIn April 2005, the U.S. National Academy of Sciences (NAS) published its Guidelines for Human Embryonic Stem Cell Research. These voluntary guidelines are among the most permissive in the world—in a country that prohibits federal funding of research to derive human embryonic stem (hES) cells (cells that can self-renew or differentiate into most cells in the human body). One of the few research prohibitions in the NAS guidelines concerns the creation of certain kinds of human–nonhuman chimeras. A chimera is an organism with a mixture of cells from two different organisms, from the same or different species. Figure 1 provides a useful overview of different types of chimeras.